GSK receives US FDA approval for Jemperli to treat advanced solid tumours
GARNET study demonstrated an objective response rate of 41.6 per cent across dMMR solid tumours
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.